Google seeks FDA approval for new passive heart rate monitoring technology

Google has developed the Fitbit algorithm,capable of passively monitoring heart rate. But to sell smartwatches with this technology as a medical device, you first need to get approval from the US Food and Drug Administration (FDA).

Fitbit research that couldEveryone who wants to participate will start in 2020. The goal of the development was to test how accurately the technology could detect irregular heart rhythms or arrhythmias.

The system itself uses photoplethysmography to obtain data, which allows you to passively track blood flow in the wrist and thus detect abnormalities.
According to a Google study, it turned out that the device will determine the arrhythmia with an accuracy of up to 98%.

If the FDA approves the technology, the corporationthey plan to make a grid of applications that will show the nearest pharmacies, clinics, available places for appointments with doctors. How Fitbit will work in countries other than the United States, where it is planned to initially launch the network, is not yet known, but the technology is definitely useful and has potential.